Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by somweyungguyon Oct 05, 2016 10:44pm
169 Views
Post# 25315236

RE:Numbers are fluid take the 650 advertised at the interim...

RE:Numbers are fluid take the 650 advertised at the interim...I do believe that ALL investors deserved to know that 600 was the required patient count, versus the 650 communicated by the company.  It almost felt as though Walker felt obligated to explain the 600 to the AGM audience.  The difference of 50 people could easily have added an additional 5 to 10 cents to the 29 CENT financing that resulted from the increased requirement to the 650 people.

Remember that this financing saw Birch Hill and Toray share the first 33M shares ( 17M & 16M ), a 10M share chunk to other investors and an additional 12M shares months later at 55 CENTS.

The number moving up to 650 from 600 was beneficial to the lower 29 CENT financing.

Sqr
Bullboard Posts